Implementation of an AI-Driven Workflow for Daily Dose Reconstruction in Prostate Cancer Radiotherapy
Cancers · 02.06.2026 · 18 (11) · 1826
DOI: 10.3390/cancers18111826 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 02.06.2026. Verfasst von Jessica Prunaretty und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institut du Cancer de Montpellier, 34090 Montpellier, France. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: This study evaluated the daily delivered dose in prostate cancer patients using the automated artificial intelligence (AI)-based software Adaptbox (v2.3.2, Therapanacea). The aim was to assess target coverage and organ-at-risk (OAR) exposure.
Methods
Twenty patients were included. All received 80 Gy in 40 fractions to the prostate and 56 Gy simultaneously to the seminal vesicles using two-arc VMAT on a TrueBeam STx, with daily CBCT for setup. For each fraction, CBCT images were imported into Adaptbox. A synthetic CT (sCT) was generated using a deep learning algorithm. OARs were automatically segmented, while targets were propagated from the planning CT (pCT) using rigid registration. Dose calculation was performed using Adaptbox’s collapse-cone algorithm. Dose parameters were extracted for each session and compared with planned values.
Results
All 800 fractions were analyzed. The planning target volume (PTV) remained consistent with planning, with a maximum deviation of 0.1% for both PTVs. For the rectum, 78.38%, 77.75%, and 78.13% of fractions exceeded planned doses for V70Gy, V76Gy and V80Gy, respectively. One patient had five consecutive fractions with >5% deviation across all rectal metrics. For the bladder, 52.34% of fractions exceeded the planned V80Gy, and two patients had ≥5 consecutive fractions with >5% deviation; however, this was attributed to contouring inaccuracies.
Conclusions
This AI-based workflow enables reliable daily dose reconstruction and can identify clinically relevant OAR dose deviations that may support adaptive interventions, although accurate contouring remains essential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institut du Cancer de Montpellier, 34090 Montpellier, France.
ORCID-Profile: Jessica Prunaretty, Olivier Riou, Pascal Fenoglietto
Zitieren
APA
Prunaretty, J., Baudouin, T., Riou, O., Azria, D., & Fenoglietto, P. (2026). Implementation of an AI-Driven Workflow for Daily Dose Reconstruction in Prostate Cancer Radiotherapy. Cancers, 18(11), 1826. https://doi.org/10.3390/cancers18111826
Vancouver
Prunaretty J, Baudouin T, Riou O, Azria D, Fenoglietto P. Implementation of an AI-Driven Workflow for Daily Dose Reconstruction in Prostate Cancer Radiotherapy. Cancers. 2026;18(11):1826. doi:10.3390/cancers18111826
BibTeX
@article{Prunaretty2026,
author = {Prunaretty, Jessica and Baudouin, Tom and Riou, Olivier and Azria, David and Fenoglietto, Pascal},
title = {Implementation of an AI-Driven Workflow for Daily Dose Reconstruction in Prostate Cancer Radiotherapy},
journal = {Cancers},
year = {2026},
volume = {18},
number = {11},
pages = {1826},
doi = {10.3390/cancers18111826}
}
EUVIMED